FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/08/2022
Voltar para busca
Dado oficial do USPTO
UPCARE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
16/08/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
21/10/2020
Data de registro
22/02/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
22/02/2022
Última transação
22/02/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
AU
Examinador
RIBAUDO, MICHELLE
Unidade examinadora
N80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "UPCARE" in black stylized font placed below two interlocking diagonal oblong shapes, with the top left shape being in red, the top right shape in green, the bottom left shape in orange and the bottom right shape in blue. The color white represents background, outlining, shading and/or transparent areas and is/are not part of the mark.
Titulares e representantes
Titulares
APEX BIOTECH RESEARCH PTY LTD
Representantes
Katherine P. Califa Foley & Lardner LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Acne treatment preparations in the form of cleansers; anti-bacterial pharmaceutical preparations; Capsules sold empty for pharmaceutical purposes; effervescent analgesic pharmaceutical preparations; Extracts of plants in capsule form for pharmaceutical purposes; Throat lozenges for pharmaceutical purposes; pharmaceutical compound eye-drops; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations containing vitamins for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for animals for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for health care for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for human use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for nasal use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for oral use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations for personal use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of acne; Pharmaceutical preparations for veterinary use for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations in the form of emulsions for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical preparations in the form of throat lozenges; Pharmaceutical preparations in the form of tablets for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical products for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical products derived from natural sources for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical products for use by humans for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical products in gel form for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; Pharmaceutical tablets for anti-agingfor the treatment and prevention of respiratory illnessesdiabetesneuro-degenerationcentral nervous system disordersfor the maintenancesupportimprovement of brain health; plant extracts for pharmaceutical use; Drug delivery agents in the form of tablets that facilitate the delivery of pharmaceutical preparations; medicated mouth spray; mouth sprays for medical use; medicated throat sprays; medicated mouthwashes; medical mouthwashes; mouthwashes and gargles for medical purposes; dietary supplements; dietary supplements for animals; herbal dietary supplements; vitamin supplements; vitamin supplements for animals; Nutritionally fortified herbal beverages for medicinal use; medical toothpastes; medicated toothpaste; eye drops; dietary supplements with a cosmetic effect
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/07/2022
FIMP
FINAL DISPOSITION PROCESSED
27/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
22/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
22/02/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/12/2021
PUBO
PUBLISHED FOR OPPOSITION
07/12/2021
GPNX
NOTIFICATION PROCESSED BY IB
06/12/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/11/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2021
RFNT
REFUSAL PROCESSED BY IB
25/04/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/04/2021
RFRR
REFUSAL PROCESSED BY MPU
05/04/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/03/2021
CNRT
NON-FINAL ACTION WRITTEN
28/03/2021
DOCK
ASSIGNED TO EXAMINER
22/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
08/12/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
26/11/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UPCARE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.